Santa Barbara Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$157M Buy
1,070,728
+320,629
+43% +$46.5M 2.44% 19
2018
Q4
$100M Buy
750,099
+444
+0.1% +$72.8K 1.61% 38
2018
Q3
$143M Sell
749,655
-12,828
-2% -$2.36M 2.07% 30
2018
Q2
$127M Sell
762,483
-7,923
-1% -$1.27M 1.94% 33
2018
Q1
$130M Buy
770,406
+234,428
+44% +$39.3M 1.99% 29
2017
Q4
$87.7M Buy
+535,978
New +$96.2M 1.33% 40

Other funds holding AGN

Santa Barbara Asset Management's AGN Position: Q1 2019 in Review

Santa Barbara Asset Management increased its Allergan plc (AGN) stake by 43% in Q1 2019, buying an estimated $46.5M and bringing the position to 1,070,728 shares worth $157M. The position accounts for 2.44% of the portfolio, ranked #19.

Santa Barbara Asset Management first reported a position in AGN in Q4 2017 and has held it in 6 quarters since. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Santa Barbara Asset Management held 1,070,728 shares of Allergan plc worth $157M as of Q1 2019.
  • Santa Barbara Asset Management bought 320,629 Allergan plc shares in Q1 2019, an estimated $46.5M.
  • Allergan plc made up 2.44% of Santa Barbara Asset Management's portfolio in Q1 2019, its #19 holding.
  • Santa Barbara Asset Management first reported a position in Allergan plc in Q4 2017 and has held it in 6 quarters since.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Santa Barbara Asset Management's 13F filing for Q1 2019, filed 14 May 2019.